Contact Us

Antitope Ltd
Babraham Research Campus
Babraham
Cambridge CB22 3AT
United Kingdom

Telephone: +44(0) 1223 496190
Fax: +44(0) 1223 496191
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

PolyTherics Ltd
The London Bioscience Innovation Centre
2 Royal College Street
London NW1 0NH
United Kingdom

Telephone: +44 (0)20 7691 4927
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

2009

 
26.10.2009
Antitope Ltd. UK Announces EpiScreen Collaboration With Centre de Recherche du Services de Sante des Armées, France
Cambridge, UK - 6 October 2009 - Antitope Ltd. ("Antitope") today announced a research collaboration with the French Centre de Recherche du Service de Santé des Armées ("CRSSA") in which Antitope will apply its proprietary EpiScreenTM  technology to map T cell...
26.10.2009
Meet Antitope at BIO Europe 2009 (Vienna, Austria 2nd - 4th Nov)
Antitope will be participating in the Business Partnering Forum at the BIO International Convention and welcome the opportunity to discuss potential collaborations with companies that are interested in assessing and/or removing immunogenicity from protein therapeutics. Meetings can be arranged...
08.10.2009
ImmunoCellular Therapeutics Announces Successful Humanization of Two Antibody Candidates
LOS ANGELES, CA -- ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has completed humanization of ICT-37 and ICT-109. This humanization was done in...
29.06.2009
Antitope Ltd and Vascular Pharmaceuticals Enter into a Antibody Research Agreement
CAMBRIDGE, UK - 29th June, 2009 - Antitope, a privately held biotechnology company, today announced a research agreement with Vascular Pharmaceuticals, Inc. for the generation of therapeutic antibodies for treatment of vascular disease. The agreement brings together Vascular Pharmaceuticals'...
07.05.2009
Meet Antitope at BIO International Convention 2009 (Atlanta, GA, USA 18th - 21st May)
Antitope will be participating in the Business Partnering Forum at the BIO International Convention and welcome the opportunity to discuss potential collaborations with companies that are interested in assessing and/or removing immunogenicity from protein therapeutics. Meetings can be arranged...
05.05.2009
Antitope Ltd. Announces EpiScreen Agreement With GlaxoSmithKline plc.
5th May 2009 -Antitope Ltd., a Cambridge (UK)-based biotechnology company specialising in immunogenicity testing and engineering of therapeutic antibodies/proteins, today announced the signing of a further research collaboration with GlaxoSmithKline plc. (GSK). Under the collaboration, Antitope...
08.04.2009
Antitope, Ltd., Announces Antibody Research Agreement With NKT Therapeutics, Inc.
Cambridge UK, 8th April 2009 - Antitope Ltd. ("Antitope") today announced a research agreement with NKT Therapeutics Inc ("NKT") for the generation of therapeutic monoclonal antibodies. Under the Agreement, Antitope will apply its proprietary Composite Human AntibodyTM...
25.03.2009
Antitope to Present at Visiongain Monoclonal Antibodies conference, London, UK, 25 March 2009
Dr. Matthew Baker, Chief Scientific Officer of Antitope, will be giving a presentation entitled "Novel Antibodies for Breast and Prostate Cancer " at this year's Visiongain Monoclonal Antibodies conference in London. The presentation will discuss the concept of therapeutic antibodies...
23.01.2009
Antitope, Ltd., and Opsona Therapeutics, Ltd., announce successful Composite Human Antibody project
January 2009 Antitope Ltd., a leader in the generation of therapeutic human antibodies with reduced immunogenicity, and Opsona Therapeutics, Ltd., a leader in the development of therapeutics for the treatment of autoimmune/inflammatory disease, today announced the completion of a successful...
13.01.2009
Antitope to Present at PepTalk at San Diego, California, USA, 12 January 2009
Dr. Frank Carr, Director for Biologics Research of Antitope, will be giving a presentation entitled "Therapeutic Antibodies Without Helper T Cell Epitopes" at this year's PepTalk conference in San Diego. The presentation will discuss the concept of therapeutic antibodies without helper T...